Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-23-015040
Filing Date
2023-05-01
Accepted
2023-05-01 17:26:14
Documents
6

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 623219
2 ex107.htm EX-FILING FEES 42123
3 form424b5_001.jpg GRAPHIC 4182
4 form424b5_002.jpg GRAPHIC 3060
5 form424b5_003.jpg GRAPHIC 4701
6 form424b5_004.jpg GRAPHIC 3059
  Complete submission text file 0001493152-23-015040.txt   687629
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271542 | Film No.: 23875333
SIC: 2834 Pharmaceutical Preparations